These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 10179922)

  • 41. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rescue strategies against non-steroidal anti-inflammatory drug-induced gastroduodenal damage.
    Lim YJ; Lee JS; Ku YS; Hahm KB
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1169-78. PubMed ID: 19682191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: retrospective cohort study of an elderly population.
    Rahme E; Joseph L; Kong SX; Watson DJ; LeLorier J
    Arthritis Rheum; 2000 Apr; 43(4):917-24. PubMed ID: 10765939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S401-13. PubMed ID: 12416790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Guideline 'NSAID use and the prevention of gastric damage'].
    Moens HJ; van Croonenborg JJ; Al MJ; van den Bemt PM; Lourens J; Numans ME;
    Ned Tijdschr Geneeskd; 2004 Mar; 148(13):604-8. PubMed ID: 15083624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NSAID and gastropathy: a rheumatologist's review.
    Roth SH
    J Rheumatol; 1988 Jun; 15(6):912-9. PubMed ID: 3047383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy].
    Lanas A
    Rev Gastroenterol Mex; 2004; 69(4):251-60. PubMed ID: 15765979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee.
    Pincus T; Koch GG; Sokka T; Lefkowith J; Wolfe F; Jordan JM; Luta G; Callahan LF; Wang X; Schwartz T; Abramson SB; Caldwell JR; Harrell RA; Kremer JM; Lautzenheiser RL; Markenson JA; Schnitzer TJ; Weaver A; Cummins P; Wilson A; Morant S; Fort J
    Arthritis Rheum; 2001 Jul; 44(7):1587-98. PubMed ID: 11465710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prescribing rationale and budgetary outcomes associated with the introduction of a combined formulation of diclofenac sodium and misoprostol in Canada.
    Sclar DA; Robison LM; Maheu A; Skaer TL
    J Int Med Res; 1995; 23(6):439-48. PubMed ID: 8746611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Economic evaluation of the use of diclofenac/misoprostol in the treatment of osteoarticular diseases].
    Soto Alvarez J
    An Med Interna; 2000 Sep; 17(9):477-84. PubMed ID: 11100534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.
    Moore RA; Derry S; Phillips CJ; McQuay HJ
    BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary?
    Laine L
    Rev Gastroenterol Disord; 2004; 4 Suppl 4():S33-41. PubMed ID: 15580145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The appropriate use of NSAIDs in arthritic conditions.
    Moskowitz RW
    Am J Orthop (Belle Mead NJ); 1996 Sep; 25(9 Suppl):4-6. PubMed ID: 8886211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
    Koch M
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups.
    Spiegel BM; Chiou CF; Ofman JJ
    Arthritis Rheum; 2005 Apr; 53(2):185-97. PubMed ID: 15818647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The cost effectiveness of diclofenac plus misoprostol compared with diclofenac monotherapy in patients with rheumatoid arthritis.
    Al MJ; Michel BC; Rutten FF
    Pharmacoeconomics; 1996 Aug; 10(2):141-51. PubMed ID: 10163417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacoeconomic aspects of non-steroidal anti-inflammatory drug gastropathy.
    Walan A; Wahlqvist P
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S79-88. PubMed ID: 10379474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.